A total of 50% of patients undergoing IVF treatment has previously been estimated to fulfill the POSEIDON classification criteria; importantly, although the reproductive prognosis differs between patients, POSEIDON patients share the same characteristic of a low ovarian response to exogenous gonadotropin stimulation—independent of age. POSEIDON patients require focused attention as regards ovarian stimulation in order to increase the chances of having at least one euploid blastocyst for transfer—the success criterion for stimulation set forth by the POSEIDON Group. The key to success seems to be individualization in all steps of treatment. In this perspective article we discuss the future impact of the POSEIDON stratification for daily clinical practice as well as for research.

Future perspectives of PoseidOn stratification for clinical practice and research / Humaidan, P.; Marca, A. L.; Alviggi, C.; Esteves, S. C.; Haahr, T.. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 10:JULY(2019), p. 439. [10.3389/fendo.2019.00439]

Future perspectives of PoseidOn stratification for clinical practice and research

Alviggi C.;
2019

Abstract

A total of 50% of patients undergoing IVF treatment has previously been estimated to fulfill the POSEIDON classification criteria; importantly, although the reproductive prognosis differs between patients, POSEIDON patients share the same characteristic of a low ovarian response to exogenous gonadotropin stimulation—independent of age. POSEIDON patients require focused attention as regards ovarian stimulation in order to increase the chances of having at least one euploid blastocyst for transfer—the success criterion for stimulation set forth by the POSEIDON Group. The key to success seems to be individualization in all steps of treatment. In this perspective article we discuss the future impact of the POSEIDON stratification for daily clinical practice as well as for research.
2019
Future perspectives of PoseidOn stratification for clinical practice and research / Humaidan, P.; Marca, A. L.; Alviggi, C.; Esteves, S. C.; Haahr, T.. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 10:JULY(2019), p. 439. [10.3389/fendo.2019.00439]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/818309
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 15
social impact